More from Stocks
Similar to biotech, the small adtech space has been hammered in recent quarters and has likely hit oversold territory.
These recently downgraded names are displaying both quantitative and technical deterioration.
Remember, behind every bear market a bull is waiting. Here's how to survive and thrive while stocks growl.
The action Friday is a good start, but it requires much more work before it can be trusted.